Compare Organon Pharma Indonesia Tbk. (SCPI) vs Salim Ivomas Pratama Tbk. (SIMP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Salim Ivomas Pratama Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Salim Ivomas Pratama Tbk. trades at Rp615 (market cap 9.61T, 18.49M 24h volume). The key difference: Salim Ivomas Pratama Tbk. is far larger — about 92× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SIMP | |
|---|---|---|
Market Cap | 104.4B | 9.61T |
Volume | — | 18.49M |
Lot | — | 184.87K |
Turnover | — | 11.38B |
Average Price | — | 615.52 |
Value | — | 11.38B |
Indicative Equilibrium Price | — | 615 |
Indicative Equilibrium Volume | — | 2.65K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Salim Ivomas Pratama Tbk.
PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Read more on SIMP →
